Ye Shu, Xie Dao-Jun, Zhou Peng, Gao Hua-Wu, Zhang Meng-Ting, Chen Da-Bao, Qin Yun-Peng, Lei Xin, Li Xin-Quan, Liu Juan, Cheng Ya-Xun, Yao Yong-Chuan, Cai Biao, Shen Guo-Ming
School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei 230012, Anhui Province, China.
Institute of Integrated Chinese and Western Medicine, Anhui Academy of Chinese Medicine, Hefei 230012, Anhui Province, China.
Evid Based Complement Alternat Med. 2021 Jun 9;2021:5514175. doi: 10.1155/2021/5514175. eCollection 2021.
Huang-Pu-Tong-Qiao formula (HPTQ), a traditional Chinese medicine (TCM) formula used to improve cognitive impairment. However, the underlying neuroprotective mechanism of HPTQ treated for diabetic cognitive dysfunction (DCD) remains unclear. The purpose of this study was to investigate the neuroprotective mechanism of HPTQ in DCD mice based on molecular docking.
To investigate the neuroprotective effect of HPTQ in DCD, the Morris water maze (MWM), novel object recognition (NOR) test was used to detect the learning and memory changes of mice; hematoxylin-eosin (HE) staining was used to investigate the damage of hippocampal neurons; the western blot (WB) was used to examine the level of brain-derived neurotrophic factor (BDNF) of hippocampus. To investigate the neuroprotective mechanism of HPTQ in DCD, molecular docking was used to predict the possible target proteins of different active components in HPTQ and then the WB was used to verify the expression of key target proteins in the hippocampus of mice.
HPTQ improved the learning and memory ability, hippocampal neuron damage, and the level of BDNF in the hippocampus of the DCD model treated with HFD/STZ for 12 weeks. Besides, the results of molecular docking showed that the main chemical components of HPTQ could be well combined with the targets of Bcl-2-associated X (Bax) and B-cell lymphoma2 (Bcl-2) and caspase-3. The levels of Bax/Bcl-2 protein ratio and caspase-3 increased in the DCD model while the HPTQ inhibited it. In addition, HPTQ restored DCD-induced decline of p-CREB, BDNF, TrkB, and p-Akt in the hippocampus.
These data indicated that HPTQ ameliorates the hippocampus apoptosis in diabetic cognitive dysfunction mice by activating CREB/BDNF/TrkB signaling pathway.
黄浦通窍方(HPTQ)是一种用于改善认知障碍的中药方剂。然而,HPTQ治疗糖尿病认知功能障碍(DCD)的潜在神经保护机制尚不清楚。本研究旨在基于分子对接研究HPTQ对DCD小鼠的神经保护机制。
为研究HPTQ对DCD的神经保护作用,采用莫里斯水迷宫(MWM)、新物体识别(NOR)试验检测小鼠的学习和记忆变化;苏木精-伊红(HE)染色观察海马神经元损伤情况;蛋白质免疫印迹法(WB)检测海马脑源性神经营养因子(BDNF)水平。为研究HPTQ对DCD的神经保护机制,采用分子对接预测HPTQ中不同活性成分可能的靶蛋白,然后用WB验证小鼠海马中关键靶蛋白的表达。
HPTQ改善了高脂饮食/链脲佐菌素(HFD/STZ)处理12周的DCD模型小鼠的学习和记忆能力、海马神经元损伤以及海马中BDNF水平。此外,分子对接结果表明,HPTQ的主要化学成分可与Bcl-2相关X蛋白(Bax)、B细胞淋巴瘤2蛋白(Bcl-2)和半胱天冬酶-3的靶点良好结合。DCD模型中Bax/Bcl-2蛋白比值和半胱天冬酶-3水平升高,而HPTQ可抑制其升高。此外,HPTQ恢复了DCD诱导的海马中磷酸化环磷腺苷反应元件结合蛋白(p-CREB)、BDNF、酪氨酸激酶受体B(TrkB)和磷酸化蛋白激酶B(p-Akt)的下降。
这些数据表明,HPTQ通过激活CREB/BDNF/TrkB信号通路改善糖尿病认知功能障碍小鼠的海马细胞凋亡。